March 22, 2009
Leuven - VIB scientists connected to the K.U. Leuven have identified a molecule that can form the basis for a new therapy for Alzheimer's disease. This is the first step toward a medicine that could actually stop the progress of Alzheimer's. Existing medicines can at best limit the loss of memory during the first phases of the disease. The authoritative journal Science is publishing the results of this research. A first step, however, is still a long way from an approved drug - even if everything goes well, it will be another 15 years before the medicine becomes available.
Related Websites
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment